What does the evidence say about Zinc Sleep Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Zinc Sleep Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit. [Menon R (2026); evidence level 1] - Level of evidence 1 (Systematic review of RCTs with low-moderate heterogeneity). [Menon R (2026); evidence level 1] - Objective To review the effectiveness of over-the-counter (OTC) treatments in reducing tinnitus symptom severity as measured by the Tinnitus Handicap Inventory (THI) in randomized controlled trials. [Menon R (2026); evidence level 1] - Methods A comprehensive search was conducted in PubMed, Embase, Cochrane CENTRAL, ClinicalTrials.gov, and WHO ICTRP through March 2025. [Menon R (2026); evidence level 1] - Hypertension represents the predominant risk factor for cardiovascular disease morbidity and mortality; with significant healthcare utilization and expenditure. [Sinclair J (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.